The content on this site is intended for healthcare professionals only
Dr Philip Poortmans spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about general advances in breast cancer over time.
Dr Poortmans gives an outline of how our treatment of breast cancer has changed over the last couple of decades.
This includes better treatment options, diagnostics, organisation of cancer, and surgery.
He then touches some of the issues faced by LMICs, emphasising the need for high quality of and specificity of surgeons.
ASCO GU 2026: Updates in metastatic prostate cancer
Burden and trends of breast cancer worldwide: Opportunities for prevention?
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
The advantages of IORT for early breast cancer treatment
Neo-adjuvant therapy for different cancers in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center
